Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Asuragen's AsuraSeq Cancer Panels


Asuragen has launched as a service three sequencing-based cancer panels: AsuraSeq-1000, AsuraSeq-35, and AsuraSeq-8, which target 1,000, 35, and eight amplicons from 52, 16, and five known cancer genes, respectively.

The company offers AsuraSeq-1000 on the Illumina Genome Analyzer, while the others are offered on the Ion Torrent PGM. Additionally, it is also offering Ion's AmpliSeq Cancer Panel, which targets 190 amplicons from 46 genes. All panels are sequenced to greater than 1,000-fold coverage, and the company will report mutations down to a 5 percent prevalence.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.